PortfoliosLab logoPortfoliosLab logo
ERNA vs. BNAI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ERNA vs. BNAI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eterna Therapeutics Inc (ERNA) and Brand Engagement Network Inc (BNAI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ERNA achieves a -81.53% return, which is significantly lower than BNAI's 443.10% return.


ERNA

1D
-8.58%
1M
-9.92%
6M
-82.95%
YTD
-81.53%
1Y
-88.64%
3Y*
-82.61%
5Y*
-85.62%
10Y*
-62.20%

BNAI

1D
-10.70%
1M
-41.04%
6M
281.82%
YTD
443.10%
1Y
259.69%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ERNA vs. BNAI - Yearly Performance Comparison


2026 (YTD)20252024
ERNA
Eterna Therapeutics Inc
-81.53%-72.79%-86.88%
BNAI
Brand Engagement Network Inc
443.10%-76.18%-90.12%

Correlation

The correlation between ERNA and BNAI is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.04

Correlation (All Time)
Calculated using the full available price history since Mar 14, 2024

0.05

Fundamentals

Market Cap

ERNA:

$1.74M

BNAI:

$61.25M

EPS

ERNA:

-$23.80

BNAI:

-$2.01

PB Ratio

ERNA:

0.64

BNAI:

15.93

Total Revenue (TTM)

ERNA:

$0.00

BNAI:

$275.12K

Gross Profit (TTM)

ERNA:

-$69.00K

BNAI:

$0.00

EBITDA (TTM)

ERNA:

-$11.25M

BNAI:

-$8.76M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ERNA vs. BNAI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ERNA
ERNA Risk / Return Rank: 1111
Overall Rank
ERNA Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
ERNA Sortino Ratio Rank: 1010
Sortino Ratio Rank
ERNA Omega Ratio Rank: 1111
Omega Ratio Rank
ERNA Calmar Ratio Rank: 44
Calmar Ratio Rank
ERNA Martin Ratio Rank: 99
Martin Ratio Rank

BNAI
BNAI Risk / Return Rank: 8686
Overall Rank
BNAI Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
BNAI Sortino Ratio Rank: 9898
Sortino Ratio Rank
BNAI Omega Ratio Rank: 9696
Omega Ratio Rank
BNAI Calmar Ratio Rank: 8787
Calmar Ratio Rank
BNAI Martin Ratio Rank: 8181
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ERNA vs. BNAI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eterna Therapeutics Inc (ERNA) and Brand Engagement Network Inc (BNAI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ERNABNAIDifference
Sharpe ratioReturn per unit of total volatility

-1.29

Sortino ratioReturn per unit of downside risk

-5.81

Omega ratioGain probability vs. loss probability

0.86

1.55

-0.69

Calmar ratioReturn relative to maximum drawdown

-0.95

3.16

-4.12

Martin ratioReturn relative to average drawdown

-1.39

5.51

-6.89

ERNA vs. BNAI - Sharpe Ratio Comparison

The current ERNA Sharpe Ratio is -0.58, which is lower than the BNAI Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of ERNA and BNAI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ERNA vs. BNAI - Drawdown Comparison

The maximum ERNA drawdown since its inception was -100.00%, roughly equal to the maximum BNAI drawdown of -99.13%. Use the drawdown chart below to compare losses from any high point for ERNA and BNAI.


Loading charts...

Drawdown Indicators


ERNABNAIDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-99.13%

-0.87%

Max Drawdown (1Y)

Largest decline over 1 year

-93.32%

-82.63%

-10.69%

Max Drawdown (3Y)

Largest decline over 3 years

-99.67%

Max Drawdown (5Y)

Largest decline over 5 years

-100.00%

Max Drawdown (10Y)

Largest decline over 10 years

-100.00%

Current Drawdown

Current decline from peak

-100.00%

-90.84%

-9.16%

Average Drawdown

Average peak-to-trough decline

-86.18%

-88.26%

+2.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

63.90%

47.39%

+16.51%

Volatility

ERNA vs. BNAI - Volatility Comparison

The current volatility for Eterna Therapeutics Inc (ERNA) is 27.18%, while Brand Engagement Network Inc (BNAI) has a volatility of 31.92%. This indicates that ERNA experiences smaller price fluctuations and is considered to be less risky than BNAI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ERNABNAIDifference

Volatility (1M)

Calculated over the trailing 1-month period

27.18%

31.92%

-4.74%

Volatility (6M)

Calculated over the trailing 6-month period

129.63%

210.34%

-80.71%

Volatility (1Y)

Calculated over the trailing 1-year period

152.28%

368.76%

-216.48%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

114.16%

290.71%

-176.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

149.11%

290.71%

-141.60%

Dividends

ERNA vs. BNAI - Dividend Comparison

Neither ERNA nor BNAI has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ERNA vs. BNAI - Financials Comparison

This section allows you to compare key financial metrics between Eterna Therapeutics Inc and Brand Engagement Network Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00K200.00K300.00K400.00K500.00KJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
200.00K
(ERNA) Total Revenue
(BNAI) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ERNA and BNAI have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BNAI has higher volatility (31.92%) compared to ERNA (27.18%). In terms of maximum drawdown, ERNA dropped -100.00% vs BNAI's -99.13%.

BNAI currently has the higher Sharpe Ratio (0.71 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ERNA and BNAI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer